Frontiers in cancer immunotherapy-a symposium report.

Cable, Jennifer, Greenbaum, Benjamin, Pe'er, Dana, Bollard, Catherine M, Bruni, Sofia, Griffin, Matthew E, Allison, James P, Wu, Catherine J, Subudhi, Sumit K, Mardis, Elaine R, Brentjens, Renier, Sosman, Jeffry A, Cemerski, Saso, Zavitsanou, Anastasia-Maria, Proia, Theresa, Egeblad, Mikala, Nolan, Garry, Goswami, Sangeeta, Spranger, Stefani, Mackall, Crystal L (November 2020) Frontiers in cancer immunotherapy-a symposium report. Annals of the New York Academy of Sciences. ISSN 0077-8923

URL: https://www.ncbi.nlm.nih.gov/pubmed/33184911
DOI: 10.1111/nyas.14526

Abstract

Cancer immunotherapy has dramatically changed the approach to cancer treatment. The aim of targeting the immune system to recognize and destroy cancer cells has afforded many patients the prospect of achieving deep, long-term remission and potential cures. However, many challenges remain for achieving the goal of effective immunotherapy for all cancer patients. Checkpoint inhibitors have been able to achieve long-term responses in a minority of patients, yet improving response rates with combination therapies increases the possibility of toxicity. Chimeric antigen receptor T cells have demonstrated high response rates in hematological cancers, although most patients experience relapse. In addition, some cancers are notoriously immunologically "cold" and typically are not effective targets for immunotherapy. Overcoming these obstacles will require new strategies to improve upon the efficacy of current agents, identify biomarkers to select appropriate therapies, and discover new modalities to expand the accessibility of immunotherapy to additional tumor types and patient populations.

Item Type: Paper
Subjects: diseases & disorders > cancer
diseases & disorders
Investigative techniques and equipment
diseases & disorders > neoplasms
Investigative techniques and equipment > biomarker
diseases & disorders > cancer > drugs and therapies
diseases & disorders > cancer > drugs and therapies > Immunotherapy
CSHL Authors:
Communities: CSHL labs > Egeblad lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: 13 November 2020
Date Deposited: 03 Feb 2021 16:47
Last Modified: 29 Jan 2024 20:34
URI: https://repository.cshl.edu/id/eprint/39840

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving